KERATRON ACQUISITION

FE-Group srl Acquires Keratron and Revolutionizes Corneal Topography

Solbiate Olona, September 2024 – FE-Group srl, a leading Italian company in the ophthalmic sector, is thrilled to announce the definitive acquisition of the business unit of Optikon BVI dedicated to the production of Keratron corneal topographers.

Having already signed an agreement in September 2023, FE-Group has now fully acquired this prestigious brand, globally recognized for its excellence in corneal topography. As of August 2024, the entire production of Keratron topographers has been transferred to FE-Group’s headquarters in Solbiate Olona, ensuring seamless production continuity and strengthening synergy with the Group’s other product lines.

By choosing to manufacture entirely in Italy, we guarantee the highest quality standards, maintain complete control over the entire production process, and support the local economy.

“We are incredibly proud of this significant milestone,” declares Matteo Carnaghi, CEO of FE-Group. “Keratron is a benchmark in corneal topography, and we are committed to further enhancing its potential. Thanks to our dedicated research and development team and our extensive experience in the ophthalmic sector, we are continuously introducing improvements at both the hardware and software levels, providing eye care professionals with increasingly innovative and high-performing tools.”

FE-Group, with nearly 30 years of history and a global presence, reaffirms its position as a trusted and innovative partner for the ophthalmic industry. The acquisition of Keratron marks a new milestone in the company’s growth journey and solidifies its market leadership.

Matteo Carnaghi further emphasizes, “Someone might think that transitioning from distributors to producers is challenging, but for FE-Group, it’s a natural evolution. Production is already an integral part of our business, allowing us full control over the entire process. The pride and satisfaction of creating a tool tailored to our customers’ needs is a testament to our passion for the ophthalmic sector. We are already working on groundbreaking new solutions and can’t wait to unveil them at the MIDO 2025 fair, showcasing our unwavering commitment to innovation.”